Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients.

AC does not appear to impact the activity or efficacy of ICI in advanced cancer patients. On the basis of our findings, we caution that there is insufficient evidence to support prospectively evaluating the combination of AC and immunotherapy.